CCWP
LFSC

Cedar Cove Wealth Partners’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Cedar Cove Wealth Partners’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Buy
70,126
+132
+0.2% +$5.11K 1.49% 18
2026
Q1 		$2.45M Buy
+69,994
New +$2.48M 1.29% 19

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OPA
Old Port Advisors Portland, Maine $508M AUM 50.99% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cedar Cove Wealth Partners's LFSC Position: Q2 2026 in Review

Cedar Cove Wealth Partners increased its F/m Emerald Life Sciences Innovation ETF (LFSC) stake by 0.19% in Q2 2026, buying an estimated $5.11K and bringing the position to 70,126 shares worth $3.17M. The position accounts for 1.49% of the portfolio, ranked #18.

Cedar Cove Wealth Partners first reported a position in LFSC in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold LFSC as of Q2 2026.

  • Cedar Cove Wealth Partners held 70,126 shares of F/m Emerald Life Sciences Innovation ETF worth $3.17M as of Q2 2026.
  • Cedar Cove Wealth Partners bought 132 F/m Emerald Life Sciences Innovation ETF shares in Q2 2026, an estimated $5.11K.
  • F/m Emerald Life Sciences Innovation ETF made up 1.49% of Cedar Cove Wealth Partners's portfolio in Q2 2026, its #18 holding.
  • Cedar Cove Wealth Partners first reported a position in F/m Emerald Life Sciences Innovation ETF in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q2 2026.

Based on Cedar Cove Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.